PALISADE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 USD | -4.84% |
|
-23.99% | -44.52% |
| 05-10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
| 05-07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.84M | - | - | - | - | - | |
| 62.86B | - | |||||
| 41.38B | ||||||
| 40.38B | ||||||
| 27.64B | ||||||
| 26.46B |
- Stock Market
- Equities
- SNCA Stock
- Charts Palisade Bio, Inc.
- Sector Chart
